- Eptinezumab - the new anti-CGRP monoclonal antibody for prophylactic treatment of migraine2022 | Faculty of Medicine in Pilsen
- CGRP monoclonal antibodies for migraine prophylaxis2019 | First Faculty of Medicine
- CGRP monoclonal antibodies in the treatment of migraine - indication criteria and therapeutic recommendations for the Czech Republic2020 | First Faculty of Medicine, Third Faculty of Medicine
- Does migraine treatment by blocking CGRP neuropeptide signaling also affect anti-infective immunity?2023 | Faculty of Medicine in Pilsen
- Chronická migréna2019 | First Faculty of Medicine
- From pathophysiology of migraine to monoclonal antibodies2019 | Faculty of Medicine in Pilsen
- Primary headaches - treatment today and tomorrow2018 | Faculty of Medicine in Pilsen
- News from the EAN Congress 2021 Migraine treatment in the world of evidence-based medicine2021 | Third Faculty of Medicine